| Business Summary | | LifeCell
Corporation
is
a
bioengineering
company
engaged
in
the
development
and
commercialization
of
tissue
regeneration
and
cell
preservation
products.
The
Company's
core
preservation
technology
produces
an
acellular
tissue
matrix,
which
retains
the
essential
biochemical
and
structural
components
necessary
for
normal
tissue
regeneration.
The
Company
currently
markets
three
products
based
on
this
technology:
AlloDerm
for
the
reconstructive
plastic,
burn
and
dental
markets;
Cymetra,
which
is
micronized
AlloDerm
tissue
for
the
reconstructive
plastic
and
dermatology
markets;
and
Repliform
acellular
tissue
for
the
urology
and
gynecology
market.
The
Company
also
is
developing
several
additional
products,
including
small
diameter
vascular
grafts
as
an
alternative
to
autografted
blood
vessels,
orthopedic
applications
of
its
acellular
tissue
matrix,
and
ThromboSol,
a
formulation
for
extended
storage
of
platelets. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | LifeCell
Corp.
is
a
bioengineering
company
engaged
in
the
development
and
commercialization
of
tissue
regeneration
and
cell
preservation
products.
For
the
six
months
ended
6/30/01,
total
revenues
rose
33%
to
$14.2
million.
Net
loss
applicable
to
Common
fell
37%
to
$2.3
million.
Revenues
reflect
increased
demand
for
Repliform,
Cymetra
and
AlloDerm.
Lower
loss
reflects
decreased
product
development
and
personnel
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Paul Thomas, 44 Chairman,
Pres, CEO | $427K | Steven Sobieski CFO | -- | Stephen Livesey, M.D., Ph.D., 47 Exec.
VP, CSO | 286K | William Barnhart, 57 Sr.
VP - Operations | 104K | Patrick Bergstedt, 40 VP
of Sales and Marketing | 155K | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|